Correlation Between Inozyme Pharma and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Mereo BioPharma Group, you can compare the effects of market volatilities on Inozyme Pharma and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Mereo BioPharma.
Diversification Opportunities for Inozyme Pharma and Mereo BioPharma
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Mereo is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Mereo BioPharma
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Mereo BioPharma. In addition to that, Inozyme Pharma is 1.02 times more volatile than Mereo BioPharma Group. It trades about -0.09 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.04 per unit of volatility. If you would invest 335.00 in Mereo BioPharma Group on August 24, 2024 and sell it today you would earn a total of 33.00 from holding Mereo BioPharma Group or generate 9.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Mereo BioPharma Group
Performance |
| Timeline |
| Inozyme Pharma |
| Mereo BioPharma Group |
Inozyme Pharma and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Mereo BioPharma
The main advantage of trading using opposite Inozyme Pharma and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Inozyme Pharma vs. ZyVersa Therapeutics | Inozyme Pharma vs. Sonnet Biotherapeutics Holdings | Inozyme Pharma vs. Zura Bio Limited | Inozyme Pharma vs. Phio Pharmaceuticals Corp |
| Mereo BioPharma vs. ZyVersa Therapeutics | Mereo BioPharma vs. Sonnet Biotherapeutics Holdings | Mereo BioPharma vs. Zura Bio Limited | Mereo BioPharma vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |